Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormone Receptor-positive Advanced Breast Cancer
Interventions: DRUG: chidamide combined with fulvestrant
Sponsor: Fudan University